Sensitivity to 6TdG treatment in vitro was analyzed in additional mouse SCLC cell lines 984 A (adherent, variant SCLC), and RPP (Rb, p130, and p53 triple knockout) (Fig. 1b). The gene discussed is TP53; the disease is small cell lung carcinoma.